β-Aminopropionitrile-Induced Reduction in Enzymatic Crosslinking Causes In Vitro Changes in Collagen Morphology and Molecular Composition

Abstract

Type I collagen morphology can be characterized using fibril D-spacing, a metric which describes the periodicity of repeating bands of gap and overlap regions of collagen molecules arranged into collagen fibrils. This fibrillar structure is stabilized by enzymatic crosslinks initiated by lysyl oxidase (LOX), a step which can be disrupted using β-aminopropionitrile (BAPN). Murine in vivo studies have confirmed effects of BAPN on collagen nanostructure and the objective of this study was to evaluate the mechanism of these effects in vitro by measuring D-spacing, evaluating the ratio of mature to immature crosslinks, and quantifying gene expression of type I collagen and LOX. Osteoblasts were cultured in complete media, and differentiated using ascorbic acid, in the presence or absence of 0.25mM BAPN-fumarate. The matrix produced was imaged using atomic force microscopy (AFM) and 2D Fast Fourier transforms were performed to extract D-spacing from individual fibrils. The experiment was repeated for quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Fourier Transform infrared spectroscopy (FTIR) analyses. The D-spacing distribution of collagen produced in the presence of BAPN was shifted toward higher D-spacing values, indicating BAPN affects the morphology of collagen produced in vitro, supporting aforementioned in vivo experiments. In contrast, no difference in gene expression was found for any target gene, suggesting LOX inhibition does not upregulate the LOX gene to compensate for the reduction in aldehyde formation, or regulate expression of genes encoding type I collagen. Finally, the mature to immature crosslink ratio decreased with BAPN treatment and was linked to a reduction in peak percent area of mature crosslink hydroxylysylpyridinoline (HP). In conclusion, in vitro treatment of osteoblasts with low levels of BAPN did not induce changes in genes encoding LOX or type I collagen, but led to an increase in collagen D-spacing as well as a decrease in mature crosslinks.

Elevated intracellular copper contributes a unique role to kidney fibrosis by lysyl oxidase mediated matrix crosslinking

“…Under physiological conditions, most of these molecules are assembled into microfibrils, which are arranged in parallel in quarter-staggered arrays with overlap and gap regions, assembled into threedimensional fibrils, and finally, the elastin and collagen molecules become insoluble. This process is called ECM crosslinking and is critical for the maintenance of a stable matrix 6,7 .…”

Bone quality assessment of osteogenic cell cultures by Raman microscopy

“…The relative amounts of trivalent (PYD) to divalent (deH‐DHLNL) collagen crosslinks can be estimated spectroscopically from the ratio of the deconvolved amide I bands at ~1,667 cm −1 and ~1,693 cm −1 , respectively . At present, spectroscopic measures of collagen crosslinks ratios have predominantly been obtained from mineralizing and nonmineralizing MC3T3‐E1 osteoblastic cell line . As shown in Figure e, collagen crosslinks ratios were unremarkably consistent throughout the 28‐day culture period, with the exception of the large variation observed at Day 4.…”

Structure-Function Relationship of Heart Valves in Health and Disease

“…Following the post-translational modification in the ER, the procollagen molecules are transported to the Golgi apparatus, where they are associated laterally to form small bundles, before they are secreted in the extracellular space (exocytosis). Following exocytosis, procollagen peptidases cleave the N-terminal and C-terminal propeptides, transforming the procollagen to tropocollagen molecules, approximately 300 nm long and 1.5 nm in diameter [14]. This allows the tropocollagen molecules to assemble into collagen fibrils by covalent cross-linking between two Lys or Hyl residues at the C-terminus of one tropocollagen molecule with two similar residues at the N-terminus of an adjacent molecule.…”